A Guide to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
What Is MASH?
What Causes MASH?
Who Is More Likely to Get MASH?
How Common Is MASH?
What Are the Symptoms of MASH?
How Is MASH Diagnosed?
Can Medication Reverse MASH?
Lifestyle Changes to Manage MASH: Weight Loss
Lifestyle Changes to Manage MASH: Exercise
Lifestyle Changes to Manage MASH: Change How You Eat
Lifestyle Changes to Manage MASH: Avoid Alcohol
Can You Prevent MASH?
Get Vaccinated
What Else Can You Do to Protect Your Liver?
Join a Clinical Trial
Show Sources
IMAGES PROVIDED BY:
1) iStock / Getty Images Plus
2) iStock / Getty Images Plus
3) Westend61 / Getty Images
4) iStock / Getty Images Plus
5) Garry Watson / Science Source
6) Moment / Getty Images
7) Moment / Getty Images
8) iStock / Getty Images Plus
9) iStock / Getty Images Plus
10) svariophoto / Getty Images
11) iStock / Getty Images
12) alejandrophotography / Getty Images
13) SimpleImages / Getty Images
14) The Image Bank / Getty Images
15) Solskin / Getty Images
SOURCES:
National Institute of Diabetes and Digestive and Kidney Diseases: “Definition & Facts of NAFLD & NASH,” “Treatment for NAFLD & NASH,” “Clinical Trials for NAFLD & NASH.”
American Liver Foundation: “NASH Definition & Prevalence,” “Nonalcoholic Steatohepatitis (NASH),” “NASH Treatment.”
UpToDate: “Patient education: Nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH).”
Endocrinology: “NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment.”
American Journal of Gastroenterology: “NASH Leading cause of Liver Transplant in Women: updated analysis of Indications for Liver Transplant and Ethnic and Gender Variances.”
Journal of the Endocrine Society: “PSUN121 Nonalcoholic Steatohepatitis (NASH), Race/Ethnicity, and Gender in Adult US Population of NHANES 17-18.”
Clinical Gastroenterology and Hepatology: “Racial and Ethnic Disparities in Non-alcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis.”
JAMA: “Nonalcoholic Steatohepatitis: A Review.”
Cleveland Clinic: “Non-Alcohol Related Steatohepatitis.”
Cedars Sinai: “Non-alcoholic Steatohepatitis (NASH).”
NYU Langone Health: “Five Things You Should Know About Nonalcoholic Fatty Liver Disease.”
UChicago Medicine: “What foods help prevent and reverse fatty liver disease?”
Journal of Clinical and Translational Hepatology: “Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail.”
Gene Expression: “The Effects of Physical Exercise on Fatty Liver Disease.”
Riley Children’s Health (Indiana University Health): “Nonalcoholic Steatohepatitis (NASH).”
Clinical Liver Disease: “Role of alcohol in nonalcoholic steatohepatitis: Rush university (Con) patients with nonalcoholic steatohepatitis should be abstinent from alcohol use.”
Gastroenterology & Hepatology: “Alcohol Consumption and Nonalcoholic Steatohepatitis/Nonalcoholic Fatty Liver Disease.”
National Cancer Institute Center for Cancer Research: “New insights into why smoking causes fatty liver disease.”
CDC: “Recommended Vaccines for Adults."
FDA: "FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease."